Stem cell shot for frailty? early safety trial begins
Symptom relief
Not yet recruiting
This early-stage study tests whether a stem cell product called Stemis™ is safe for older adults with mild to moderate frailty. Frailty causes weakness, slow walking, and reduced daily function, with no approved treatments. Around 12 people aged 60–85 will receive either Stemis™ …
Phase: PHASE1 • Sponsor: Ji Yan Biomedical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC